We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is a Histiocytic Sarcoma?

By S. Anderson
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Histiocytic sarcoma is a malignant form of cancer that arises from histiocytes. Histiocytes are tissue-based white blood cells, or macrophages. This cancer can arise in many parts of the body because macrophages are found in all body tissues. This type of sarcoma is generally an aggressive cancer with a poor prognosis. It is rare in humans and occurs more frequently in certain dog species.

Primary histiocytic tumors have been found in joints of the arms and legs, the gastrointestinal tract, skin, bone marrow, the spleen, the central nervous system, the lungs and even the nasal cavity. Histiocytic cancer that is found in a single site is called histiocytic sarcoma. If the cancer spreads to other organs or distant lymph nodes, it is called disseminated histiocytic sarcoma.

"Histiocyte" is a general term relating to a group of cells that share the same cell lineage. All histiocytes begin in the bone marrow as stem cells. From the bone marrow, they become monocytes and migrate into the circulatory system. These cells then leave the blood and enter tissue, where they undergo differentiation into macrophages and become part of the immune system. Macrophages respond to and engulf foreign proteins in the body, such as viruses and bacteria.

Until the early 21st century, only small numbers of human cases had been mentioned in the literature. It is possible that previous cases were misdiagnosed as non-Hodgkins lymphoma. These tumors were first classified as histiocytic sarcomas in 1970 based on similarities of the cells to macrophages. After that time, research emphasis moved to a cytochemical and immunohistochemical categorization of the tumors.

It can be very difficult to diagnose this cancer, because it is similar to other histiocytic growths. Some of these growths are non-cancerous, such as hemophagocytic syndrome. Other similar growths are malignant, such as malignant histiocytosis or monocytic leukemia. One method used to diagnose this type of sarcoma is the hemoglobin scavenger receptor protein CD163. This protein identifies cells that have a histiocytic lineage with a greater degree of specificity.

Histiocytic sarcoma is recognized as occurring in several dog breeds as well as in humans. In Bernese Mountain Dogs, a genetic familial susceptibility to the cancer has been observed. Other dogs that seem predisposed to this disease include Flat-Coated Retrievers, Golden Retrievers and Rottweilers. Symptoms of the disorder in dogs include weight loss, low energy, limping and failure to eat. Chemotherapy has been mostly unsuccessful against this form of cancer, and most dogs succumb to the disease within months of diagnosis.

There is no test for early diagnosis of this condition, and the disease typically is advanced when diagnosis is made. After diagnosis, there is rapid progression of the cancer, especially if there is lymph node involvement. The best prognosis is for single small tumors found in limbs, where surgical removal can provide a good long-term outcome.

In humans, survival rates and the average length of survival are difficult to calculate because of the rarity of the condition. Some research has shown that patients who have an advanced stage of the disease have an average survival of about seven months after diagnosis, although it is possible to survive for many years with less-advanced stages of the disease. Tumor size has been found to be a predictor of survival, with tumors equal to or larger than about 1.4 inches (3.5 cm) having the worst outcome.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.

Discussion Comments

By anon996996 — On Nov 04, 2016

My brother (based in South Africa) has been diagnosed with Histiocytic sarcoma and I was wondering if you know of anyone who is researching this form of cancer and can tell us more about this / how to treat it (if possible). I am desperate to hear if there are any reputable doctors out there who can help. --Sharon

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.